Efficacy and Safety of the Platelet-Activating Factor Receptor Antagonist BN 52021 (Ginkgolide B) in Patients with Severe Sepsis: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial

Author: Albrecht D.M.  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.24, Iss.3, 2004-01, pp. : 137-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content